Genentech: Brian Yaspan | Senior Principal Scientist, OMNI Human Genetics
CLA Dean's List | Undergraduate Students | College of Liberal Arts
Petros George Nikolinakos, MD Managing Partner and Director of Clinical Research - University Cancer & Blood Center
NC State University 2020 Commencement Program by NC State Enrollment Management and Services - Issuu
Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design | Journal of Medicinal Chemistry
Pin on admirable artists.
Gothic Fantasy
Provider Spotlight: Dr. Joel Edelstein - AZ Care Network
Coordinated Care Transforms Lives - AZ Care Network
Executive Leadership - AZ Care Network
Axion dark matter: What is it and why now? | Science Advances
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm | Science Advances
Genetic mechanisms of critical illness in COVID-19 | Nature
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke | ACS Medicinal Chemistry Letters
For Providers Archives - AZ Care Network
NC State University August 2021 Commencement Program by NC State Enrollment Management and Services - Issuu
Cytokine release syndrome in severe COVID-19 | Science
Whose Reality Counts?
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke | ACS Medicinal Chemistry Letters
Rutgers University | The State University of New Jersey
SUNY series in American Philosophy and Cultural Thought
highlight - Rutgers
AZ Care Network - A Better State of Care
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
Professor Jason Pole - Centre for Health Services Research - University of Queensland
Genentech: Christian Hammer | Senior Principal Scientist, Cancer Immunology & Human Genetics
